Brief: NeuroVive Pharmaceutical Q3 Pre-tax Loss Up At SEK 15.3 Mln

Abliva AB

20/11/2019 07:35

Nov 20 (Reuters) - NeuroVive Pharmaceutical AB  NVP.ST :
    * Q3 PRE-TAX LOSS SEK 15.3 MILLION VERSUS PROFIT SEK 15.0
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr7c53H3 
Further company coverage:  NVP.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))